283 related articles for article (PubMed ID: 23783552)
21. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications.
Guan M; Zhou X; Soulitzis N; Spandidos DA; Popescu NC
Clin Cancer Res; 2006 Mar; 12(5):1412-9. PubMed ID: 16533763
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.
Zhu YH; Fu L; Chen L; Qin YR; Liu H; Xie F; Zeng T; Dong SS; Li J; Li Y; Dai Y; Xie D; Guan XY
Cancer Res; 2013 Apr; 73(7):2298-309. PubMed ID: 23436800
[TBL] [Abstract][Full Text] [Related]
23. Involvement of annexin A8 in the properties of pancreatic cancer.
Hata H; Tatemichi M; Nakadate T
Mol Carcinog; 2014 Mar; 53(3):181-91. PubMed ID: 23001853
[TBL] [Abstract][Full Text] [Related]
24. Curcumin inhibits anchorage-independent growth of HT29 human colon cancer cells by targeting epigenetic restoration of the tumor suppressor gene DLEC1.
Guo Y; Shu L; Zhang C; Su ZY; Kong AN
Biochem Pharmacol; 2015 Mar; 94(2):69-78. PubMed ID: 25640947
[TBL] [Abstract][Full Text] [Related]
25. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
[TBL] [Abstract][Full Text] [Related]
26. DLC1 is unlikely to be a primary target for deletions on chromosome arm 8p22 in head and neck squamous cell carcinoma.
Hewitt C; Wilson P; McGlinn E; MacFarlane G; Papageorgiou A; Woodwards RT; Sloan P; Gollin SM; Paterson I; Parkinson KK; Read AP; Thakker N
Cancer Lett; 2004 Jun; 209(2):207-13. PubMed ID: 15159023
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
[TBL] [Abstract][Full Text] [Related]
28. IGSF4 promoter methylation and expression silencing in human cervical cancer.
Li J; Zhang Z; Bidder M; Funk MC; Nguyen L; Goodfellow PJ; Rader JS
Gynecol Oncol; 2005 Jan; 96(1):150-8. PubMed ID: 15589594
[TBL] [Abstract][Full Text] [Related]
29. Identification and characterization of Dlc1 isoforms in the mouse and study of the biological function of a single gene trapped isoform.
Sabbir MG; Wigle N; Loewen S; Gu Y; Buse C; Hicks GG; Mowat MR
BMC Biol; 2010 Mar; 8():17. PubMed ID: 20199662
[TBL] [Abstract][Full Text] [Related]
30. EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers.
Au SL; Wong CC; Lee JM; Wong CM; Ng IO
PLoS One; 2013; 8(6):e68226. PubMed ID: 23826380
[TBL] [Abstract][Full Text] [Related]
31. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors.
Ying J; Srivastava G; Hsieh WS; Gao Z; Murray P; Liao SK; Ambinder R; Tao Q
Clin Cancer Res; 2005 Sep; 11(18):6442-9. PubMed ID: 16166418
[TBL] [Abstract][Full Text] [Related]
32. Frequent Downregulation and Promoter Hypermethylation of DLC1: Relationship with Clinical Outcome in Gallbladder Cancer.
Singh D; Bharti A; Biswas D; Tewari M; Kar AG; Ansari MA; Singh S; Narayan G
J Gastrointest Cancer; 2022 Jun; 53(2):237-244. PubMed ID: 33417200
[TBL] [Abstract][Full Text] [Related]
33. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
34. DNA variants of DLC-1, a candidate tumor suppressor gene in human hepatocellular carcinoma.
Park SW; Durkin ME; Thorgeirsson SS; Popescu NC
Int J Oncol; 2003 Jul; 23(1):133-7. PubMed ID: 12792785
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
[TBL] [Abstract][Full Text] [Related]
36. DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas.
Yuan BZ; Jefferson AM; Baldwin KT; Thorgeirsson SS; Popescu NC; Reynolds SH
Oncogene; 2004 Feb; 23(7):1405-11. PubMed ID: 14661059
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
[TBL] [Abstract][Full Text] [Related]
38. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
39. A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth.
Li H; Li J; Su Y; Fan Y; Guo X; Li L; Su X; Rong R; Ying J; Mo X; Liu K; Zhang Z; Yang F; Jiang G; Wang J; Zhang Y; Ma D; Tao Q; Han W
Oncogene; 2014 Jun; 33(24):3109-18. PubMed ID: 23893243
[TBL] [Abstract][Full Text] [Related]
40. Demethylation of RUNX3 by vincristine in colorectal adenocarcinoma cells.
Moon JW; Lee SK; Lee JO; Kim JH; Kim N; Kim J; Kim HS; Park SH
Anticancer Res; 2014 Jan; 34(1):133-40. PubMed ID: 24403453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
